STRATEGY STUDIO / NONPROFIT PEOPLE SEARCH

BIOTECHNOLOGY INNOVATION ORGANIZATION: Form 990, tax year 2019

View the entire original 990 at ProPublica ↗

Organization
BIOTECHNOLOGY INNOVATION ORGANIZATION (EIN 52-1224577)
Tax period
2019-01-01 to 2019-12-31
Filed
2020-11-16
IRS object ID
202003219349300825
Schema version
2019v5.1
Source
Download XML · Original 990 at ProPublica

Every field in the e-filed return. Faint text is the IRS element name, for citing.

Return header ReturnHeader

FieldValueIRS element (for citing)
Return2020-11-16T07:07:42-06:00ReturnTs
Tax Period End2019-12-31TaxPeriodEndDt

Preparer Firm PreparerFirmGrp

FieldValueIRS element (for citing)
Preparer Firm EIN410746749PreparerFirmEIN

Preparer Firm Name PreparerFirmName

FieldValueIRS element (for citing)
Business Name Line1CLIFTONLARSONALLEN LLPBusinessNameLine1Txt

Preparer US Address PreparerUSAddress

FieldValueIRS element (for citing)
Address Line1901 N GLEBE ROAD SUITE 200AddressLine1Txt
CityARLINGTONCityNm
State AbbreviationVAStateAbbreviationCd
ZIP22203ZIPCd
FieldValueIRS element (for citing)
Return Type990ReturnTypeCd
Tax Period Begin2019-01-01TaxPeriodBeginDt

Filer Filer

FieldValueIRS element (for citing)
EIN521224577EIN

Business Name BusinessName

FieldValueIRS element (for citing)
Business Name Line1BIOTECHNOLOGY INNOVATION ORGANIZATIONBusinessNameLine1Txt
FieldValueIRS element (for citing)
Business Name ControlBIOTBusinessNameControlTxt
Phone2029629200PhoneNum

US Address USAddress

FieldValueIRS element (for citing)
Address Line11201 MARYLAND AVE SW NO 900AddressLine1Txt
CityWASHINGTONCityNm
State AbbreviationDCStateAbbreviationCd
ZIP20024ZIPCd

Business Officer BusinessOfficerGrp

FieldValueIRS element (for citing)
PersonSTEPHEN JASKOPersonNm
Person TitleCFOPersonTitleTxt
Phone2029629200PhoneNum
Signature2020-11-14SignatureDt
Discuss With Paid PreparerYes (1)DiscussWithPaidPreparerInd

Preparer Person PreparerPersonGrp

FieldValueIRS element (for citing)
Preparer PersonAMY CHAPMANPreparerPersonNm
PTINP00843460PTIN
Phone5712279500PhoneNum
Preparation2020-11-14PreparationDt

Filing Security Information FilingSecurityInformation

IP Address IPAddress

FieldValueIRS element (for citing)
I Pv4 Address108.48.156.67IPv4AddressTxt
FieldValueIRS element (for citing)
IP2020-11-14IPDt
IP Tm16:35:25IPTm
IP TimezoneESIPTimezoneCd
Filing License TypePFilingLicenseTypeCd
At Submission Creation Device IdDA39A3EE5E6B4B0D3255BFEF95601890AFD80709AtSubmissionCreationDeviceId
At Submission Filing Device Id87826B80F82B7742AC94E6ED7EC5993094E974B0AtSubmissionFilingDeviceId
FieldValueIRS element (for citing)
Tax2019TaxYr
Build TS2021-04-22 16:20:28ZBuildTS

Form 990 IRS990

FieldValueIRS element (for citing)
Principal OfficerJAMES C GREENWOODPrincipalOfficerNm

US Address USAddress

FieldValueIRS element (for citing)
Address Line11201 MARYLAND AVE SW NO 900AddressLine1Txt
CityWASHINGTONCityNm
State AbbreviationDCStateAbbreviationCd
ZIP20024ZIPCd
FieldValueIRS element (for citing)
Gross Receipts$96,457,553GrossReceiptsAmt
Group Return For Affiliates0GroupReturnForAffiliatesInd
Organization501cYes (X)Organization501cInd
Website AddressWWW.BIO.ORGWebsiteAddressTxt
Type Of Organization CorpYes (X)TypeOfOrganizationCorpInd
Formation1993FormationYr
Legal Domicile StateDCLegalDomicileStateCd
Activity Or MissionSUPPORT THE BIOTECHNOLOGY INDUSTRY AND TO EXPAND THE BOUNDARIES OF SCIENCE TO BENEFIT MANKIND.ActivityOrMissionDesc
Voting Members Governing Body106VotingMembersGoverningBodyCnt
Voting Members Independent106VotingMembersIndependentCnt
Total Employee222TotalEmployeeCnt
Total Volunteers148TotalVolunteersCnt
Total Gross UBI$1,008,542TotalGrossUBIAmt
Net Unrelated Bus Txbl Incm$0NetUnrelatedBusTxblIncmAmt
PY Contributions Grants$0PYContributionsGrantsAmt
CY Contributions Grants$0CYContributionsGrantsAmt
PY Program Service Revenue$72,848,062PYProgramServiceRevenueAmt
CY Program Service Revenue$75,437,314CYProgramServiceRevenueAmt
PY Investment Income$2,538,802PYInvestmentIncomeAmt
CY Investment Income$3,168,579CYInvestmentIncomeAmt
PY Other Revenue$11,923,567PYOtherRevenueAmt
CY Other Revenue$13,831,376CYOtherRevenueAmt
PY Total Revenue$87,310,431PYTotalRevenueAmt
CY Total Revenue$92,437,269CYTotalRevenueAmt
PY Grants And Similar Paid$2,626,800PYGrantsAndSimilarPaidAmt
CY Grants And Similar Paid$3,162,700CYGrantsAndSimilarPaidAmt
PY Benefits Paid To Members$0PYBenefitsPaidToMembersAmt
CY Benefits Paid To Members$0CYBenefitsPaidToMembersAmt
PY Salaries Comp Emp Bnft Paid$36,867,200PYSalariesCompEmpBnftPaidAmt
CY Salaries Comp Emp Bnft Paid$39,303,857CYSalariesCompEmpBnftPaidAmt
PY Total Prof Fndrsng Expns$0PYTotalProfFndrsngExpnsAmt
CY Total Prof Fndrsng Expns$0CYTotalProfFndrsngExpnsAmt
CY Total Fundraising Expense$0CYTotalFundraisingExpenseAmt
PY Other Expenses$47,030,501PYOtherExpensesAmt
CY Other Expenses$53,724,995CYOtherExpensesAmt
PY Total Expenses$86,524,501PYTotalExpensesAmt
CY Total Expenses$96,191,552CYTotalExpensesAmt
PY Revenues Less Expenses$785,930PYRevenuesLessExpensesAmt
CY Revenues Less Expenses-$3,754,283CYRevenuesLessExpensesAmt
Total Assets BOY$78,940,053TotalAssetsBOYAmt
Total Assets EOY$84,368,104TotalAssetsEOYAmt
Total Liabilities BOY$36,968,656TotalLiabilitiesBOYAmt
Total Liabilities EOY$36,733,362TotalLiabilitiesEOYAmt
Net Assets Or Fund Balances BOY$41,971,397NetAssetsOrFundBalancesBOYAmt
Net Assets Or Fund Balances EOY$47,634,742NetAssetsOrFundBalancesEOYAmt
Info In Schedule O Part IIIYes (X)InfoInScheduleOPartIIIInd
MissionTHE BIOTECHNOLOGY INNOVATION ORGANIZATION (BIO) REPRESENTS APPROXIMATELY 1,000 COMPANIES AND ORGANIZATIONS IN WASHINGTON DC, STATE CAPITALS, AND INTERNATIONAL FORA. BIO IS FOUNDED ON THE PRINCIPLE THAT POLICY MUST NURTURE INNOVATION IN THE LIFE SCIENCES TO OVERCOME CHALLENGES IN HEALTH CARE, AGRICULTURE, INDUSTRY, AND THE ENVIRONMENT. OUR MEMBERS REPRESENT COMPANIES OFFERING A SPECTRUM OF BIOTECHNOLOGY APPLICATIONS ACROSS MAJOR SECTORS OF THE ECONOMY. BIO MEMBERS ALSO INCLUDE UNIVERSITIES, NONPROFITS, PATIENT GROUPS, AND OTHER ORGANIZATIONS THAT PLAY AN IMPORTANT ROLE IN THE FUTURE OF THE LIFE SCIENCES. BIO'S ACTIVITIES ARE BROKEN DOWN INTO TWO PROGRAMS - ADVOCACY AND SERVICES.MissionDesc
Significant New Program Srvc0SignificantNewProgramSrvcInd
Significant Change0SignificantChangeInd
DescADVOCACY: BIOTECHNOLOGY INNOVATION ORGANIZATION (BIO)'S ADVOCACY EFFORTS REFLECT THE PRIORITIES IDENTIFIED BY THE BIO BOARD OF DIRECTORS AND THE FOUR SECTION GOVERNING BOARDS.THE BOARD OF DIRECTORS FOCUSES ON ISSUES OF IMPORTANCE TO ALL BIO MEMBERS, REGARDLESS OF THEIR SIZE OR TECHNOLOGY. THESE CROSS-CUTTING ADVOCACY ACCOMPLISHMENTS IN 2019 ARE LISTED BELOW: - SAFEGUARDED AND ADVANCED INTELLECTUAL PROPERTY PROTECTIONS, DOMESTICALLY AND INTERNATIONALLY.- FOSTERED A DIALOGUE ABOUT BIOETHICS AND PROACTIVELY ADVANCED THE SOCIALLY RESPONSIBLE USE OF BIOTECHNOLOGY.- PROMOTED INVESTMENT IN GOVERNMENT AND ACADEMIC RESEARCH.- EXPANDED OUTREACH TO FOREIGN GOVERNMENTS AND INTERNATIONAL ENTITIES TO EDUCATE ON POLICY ISSUES OF IMPORTANCE TO THE BIOTECHNOLOGY INDUSTRY AND TO IMPROVE THE INVESTMENT AND REGULATORY CLIMATE FOR BIOTECH PRODUCTS.THE HEALTH SECTION 2019 ADVOCACY ACCOMPLISHMENTS: - PROMOTED HEALTHCARE POLICIES THAT RECOGNIZE BOTH THE PROMISE AND VALUE OF INNOVATION.- ADVOCATED FOR A SAFE AND PREDICTABLE REGULATORY ENVIRONMENT FOR VALUE-BASED PAYMENT ARRANGEMENTS FOR DRUGS AND BIOLOGICS.- ENHANCED AND PROTECTED PATIENT ACCESS TO INNOVATIVE THERAPIES AND PROMOTED THE NEED FOR GREATER NONDISCRIMINATION ENFORCEMENT AGAINST INSURANCE BENEFIT DESIGNS.- ADVOCATED FOR BIOSIMILARS POLICIES THAT PROTECT PATIENT SAFETY, PROMOTE BIOMEDICAL INNOVATION, AND ADVANCE THE SCIENCE-BASED REVIEW AND APPROVAL OF BIOSIMILARS AND INTERCHANGEABLE BIOLOGICAL PRODUCTS.- PROMOTED THE VALUE OF U.S. GOVERNMENT INVESTMENTS IN PROGRAMS THAT IMPROVE ACCESS TO IMMUNIZATIONS AND FOSTER VACCINE INNOVATION, STRENGTHENED OUR ABILITY TO RESPOND TO BIOTERROR THREATS OR EMERGING INFECTIOUS DISEASES, AND ENCOURAGED DEVELOPMENT OF NEW PRODUCTS TO FIGHT ANTIMICROBIAL RESISTANCE (AMR).- INFLUENCED IMPROVEMENTS TO THE INTERNATIONAL ENVIRONMENT FOR BIOMEDICAL INNOVATION AND GLOBAL PUBLIC HEALTH PREPAREDNESS.THE EMERGING COMPANIES SECTION 2019 ADVOCACY ACCOMPLISHMENTS: - ADVANCED THE INTEREST OF EMERGING COMPANIES IN CAPITAL FORMATION AND FINANCIAL SERVICES POLICY.- ADVOCATED FOR TAX POLICIES SUPPORTING INNOVATIVE EMERGING COMPANIES AND INVESTMENT IN GROUNDBREAKING R&D; ENHANCED THE VOICE OF PRE-REVENUE, R&D-INTENSIVE BUSINESSES IN THE TAX REFORM DEBATE.- ADVOCATED FOR THE REMOVAL OF BURDENSOME FINANCIAL REPORTING REGULATIONS ON EMERGING COMPANIES.THE FOOD & AGRICULTURE SECTION 2019 ADVOCACY ACCOMPLISHMENTS: - WORKED WITH THE ADMINISTRATION AND CONGRESS TO ADVANCE IMPROVEMENTS TO THE U.S. AND GLOBAL REGULATORY SYSTEMS FOR AG-BIOTECH PRODUCTS. - WORKED WITH MEMBERS OF THE AGRICULTURAL VALUE CHAIN TO ADDRESS TRADE ISSUES IN AGRICULTURAL EXPORT MARKETS SUCH AS CHINA AND EUROPE. - ADVOCATED IN LEGISLATURES AND COURTS TO PRESERVE THE RIGHTS OF FARMERS TO PLANT GENETICALLY ENGINEERED CROPS. THE INDUSTRIAL & ENVIRONMENTAL SECTION 2019 ADVOCACY ACCOMPLISHMENTS: - SUPPORTED A RENEWABLE CHEMICALS REPORT.- ADVOCATED FOR EPA TO TREAT ALL SUSTAINABLY SOURCED BIOMASS AS ELIGIBLE MEASURES FOR EMISSIONS REDUCTION CREDIT (ERC) GENERATION. - ADVOCATED REGARDING THE IMPLEMENTATION OF THE TOXIC SUBSTANCES CONTROL ACT (TSCA) AS AMENDED BY CONGRESS, AS WELL AS ISSUES RELATING TO THE NATIONAL BIOENGINEERED FOOD DISCLOSURE ACT.- ENGAGED WITH THE ADMINISTRATION'S REVIEW OF THE COORDINATED FRAMEWORK FOR BIOTECHNOLOGY, INCLUDING WITH RESPECT TO THE REGULATION OF GENETICALLY ENGINEERED (GE) ALGAE.- URGED CONGRESS TO EXTEND A SUITE OF CRITICAL ADVANCED BIOFUELS TAX INCENTIVES BEYOND 2019.Desc

Prog Srvc Accom Acty2 ProgSrvcAccomActy2Grp

FieldValueIRS element (for citing)
DescSERVICES: BIO'S SERVICES INCLUDE CONFERENCES AND ACTIVITIES THAT BRING TOGETHER INDUSTRY STAKEHOLDERS AND INVESTORS FOR EVENTS RANGING FROM THE BIO INTERNATIONAL CONVENTION TO CONFERENCES FOR BUSINESS DEVELOPMENT EXECUTIVES.THE BIO INTERNATIONAL CONVENTION ATTRACTS APPROXIMATELY 16,000 OF THE MOST INFLUENTIAL BIOTECH AND PHARMA ATTENDEES FROM 76 COUNTRIES AND 48 U.S. STATES, AS WELL AS THE DISTRICT OF COLUMBIA, PUERTO RICO AND THE US VIRGIN ISLANDS, INCLUDING 300 MEMBERS OF THE MEDIA, AND OFFERS THREE DAYS OF PROFESSIONAL AND BUSINESS DEVELOPMENT OPPORTUNITIES. THE NET INCOME FROM THE CONVENTION SUPPORTS OUR ADVOCACY, PUBLIC OUTREACH, AND OTHER MEMBER SERVICE ACTIVITIES. THE KEY ELEMENTS OF THE BIO INTERNATIONAL CONVENTION ARE EDUCATIONAL PROGRAMMING, EXHIBITION, THE BIO BUSINESS FORUM, AND NETWORKING EVENTS. THESE ELEMENTS PROVIDE AN OPPORTUNITY FOR BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES, ACADEMIC RESEARCH INSTITUTIONS, AND INVESTORS FROM AROUND THE WORLD TO LEARN ABOUT RECENT SCIENTIFIC AND POLICY DEVELOPMENTS, AND SCHEDULE ONE-ON-ONE MEETINGS TO DISCUSS POTENTIAL BUSINESS OPPORTUNITIES. THE BIO BUSINESS FORUM AT THE CONVENTION HOSTS TENS OF THOUSANDS OF PARTNERING MEETINGS AMONG A FEW THOUSAND COMPANIES, ALONG WITH A COUPLE HUNDRED COMPANY PRESENTATIONS. THE CONVENTION HOSTS HUNDREDS OF SPEAKERS, AND OVER A THOUSAND EXHIBITIONS WITH INTERNATIONAL, REGIONAL AND STATE PAVILIONS (AND A NUMBER OF PRODUCT FOCUS ZONES).BEYOND THE CONVENTION, BIO HOSTS OR CO-HOSTS A NUMBER OF NATIONAL AND INTERNATIONAL CONFERENCES THAT PROVIDE VENUES FOR MEMBER AND NON-MEMBER COMPANIES TO PRESENT NEW DATA, MEET WITH FELLOW BIOTECH COMPANIES, AND ATTRACT FUNDING FROM INVESTORS AND OTHER ORGANIZATIONS.Desc
FieldValueIRS element (for citing)
Described In Section501c30DescribedInSection501c3Ind
Schedule B Required0ScheduleBRequiredInd
Political Campaign Acty0PoliticalCampaignActyInd
Subject To Proxy TaxYes (1)SubjectToProxyTaxInd
Donor Advised Fund0DonorAdvisedFundInd
Conservation Easements0ConservationEasementsInd
Collections Of Art0CollectionsOfArtInd
Credit Counseling0CreditCounselingInd
Donor Rstr Or Quasi Endowments0DonorRstrOrQuasiEndowmentsInd
Report Land Building EquipmentYes (1)ReportLandBuildingEquipmentInd
Report Investments Other Sec0ReportInvestmentsOtherSecInd
Report Program Related Invst0ReportProgramRelatedInvstInd
Report Other Assets0ReportOtherAssetsInd
Report Other LiabilitiesYes (1)ReportOtherLiabilitiesInd
Include FIN48 Footnote0IncludeFIN48FootnoteInd
Independent Audit Fincl StmtYes (1)IndependentAuditFinclStmtInd
Consolidated Audit Fincl Stmt0ConsolidatedAuditFinclStmtInd
School Operating0SchoolOperatingInd
Foreign Office0ForeignOfficeInd
Foreign ActivitiesYes (1)ForeignActivitiesInd
More Than5000 K To Org0MoreThan5000KToOrgInd
More Than5000 K To Individuals0MoreThan5000KToIndividualsInd
Professional Fundraising0ProfessionalFundraisingInd
Fundraising Activities0FundraisingActivitiesInd
Gaming Activities0GamingActivitiesInd
Operate Hospital0OperateHospitalInd
Grants To OrganizationsYes (1)GrantsToOrganizationsInd
Grants To Individuals0GrantsToIndividualsInd
Schedule J RequiredYes (1)ScheduleJRequiredInd
Tax Exempt Bonds0TaxExemptBondsInd
Loan Outstanding0LoanOutstandingInd
Grant To Related Person0GrantToRelatedPersonInd
Business Rln With Org Mem0BusinessRlnWithOrgMemInd
Business Rln With Fam MemYes (1)BusinessRlnWithFamMemInd
Business Rln With35 Ctrl Ent0BusinessRlnWith35CtrlEntInd
Deductible Non Cash Contri0DeductibleNonCashContriInd
Deductible Art Contribution0DeductibleArtContributionInd
Terminate Operations0TerminateOperationsInd
Partial Liquidation0PartialLiquidationInd
Disregarded Entity0DisregardedEntityInd
Related EntityYes (1)RelatedEntityInd
Related Organization Ctrl Ent0RelatedOrganizationCtrlEntInd
Activities Conducted Prtshp0ActivitiesConductedPrtshpInd
Schedule O RequiredYes (1)ScheduleORequiredInd
IRP Document186IRPDocumentCnt
IRP Document W2 G0IRPDocumentW2GCnt
Employee222EmployeeCnt
Employment Tax Returns FiledYes (1)EmploymentTaxReturnsFiledInd
Unrelated Bus Incm Over LimitYes (1)UnrelatedBusIncmOverLimitInd
Form990 T FiledYes (1)Form990TFiledInd
Foreign Financial AccountYes (1)ForeignFinancialAccountInd
Foreign CountryINForeignCountryCd
Prohibited Tax Shelter Trans0ProhibitedTaxShelterTransInd
Taxable Party Notification0TaxablePartyNotificationInd
Nondeductible Contributions0NondeductibleContributionsInd
Indoor Tanning Services0IndoorTanningServicesInd
Subj To Tax Rmnrtn Ex Prcht PymtYes (1)SubjToTaxRmnrtnExPrchtPymtInd
Subject To Excs Tax Net Invst Inc0SubjectToExcsTaxNetInvstIncInd
Info In Schedule O Part VIYes (X)InfoInScheduleOPartVIInd
Governing Body Voting Members106GoverningBodyVotingMembersCnt
Independent Voting Member106IndependentVotingMemberCnt
Family Or Business Rln0FamilyOrBusinessRlnInd
Delegation Of Mgmt Duties0DelegationOfMgmtDutiesInd
Change To Org Documents0ChangeToOrgDocumentsInd
Material Diversion Or Misuse0MaterialDiversionOrMisuseInd
Members Or StockholdersYes (1)MembersOrStockholdersInd
Election Of Board MembersYes (1)ElectionOfBoardMembersInd
Decisions Subject To Approva0DecisionsSubjectToApprovaInd
Minutes Of Governing BodyYes (1)MinutesOfGoverningBodyInd
Minutes Of CommitteesYes (1)MinutesOfCommitteesInd
Officer Mailing Address0OfficerMailingAddressInd
Local Chapters0LocalChaptersInd
Form990 Provided To Gvrn Body0Form990ProvidedToGvrnBodyInd
Conflict Of Interest PolicyYes (1)ConflictOfInterestPolicyInd
Annual Disclosure Covered PrsnYes (1)AnnualDisclosureCoveredPrsnInd
Regular Monitoring EnfrcYes (1)RegularMonitoringEnfrcInd
Whistleblower PolicyYes (1)WhistleblowerPolicyInd
Document Retention PolicyYes (1)DocumentRetentionPolicyInd
Compensation Process CEOYes (1)CompensationProcessCEOInd
Compensation Process OtherYes (1)CompensationProcessOtherInd
Investment In Joint Venture0InvestmentInJointVentureInd
Upon RequestYes (X)UponRequestInd

Books In Care Of Detail BooksInCareOfDetail

FieldValueIRS element (for citing)
PersonSTEPHEN JASKOPersonNm
Phone2029629200PhoneNum

US Address USAddress

FieldValueIRS element (for citing)
Address Line11201 MARYLAND AVENUE SW SUITE 990AddressLine1Txt
CityWASHINGTONCityNm
State AbbreviationDCStateAbbreviationCd
ZIP20024ZIPCd

Form990 Part VII Section A Form990PartVIISectionAGrp (140 entries)

TitleTitleTxtAverage Hours Per WeekAverageHoursPerWeekRtOfficerOfficerIndReportable Comp From OrgReportableCompFromOrgAmtReportable Comp From Rltd OrgReportableCompFromRltdOrgAmtOther CompensationOtherCompensationAmtHighest Compensated EmployeeHighestCompensatedEmployeeIndKey EmployeeKeyEmployeeIndIndividual Trustee Or DirectorIndividualTrusteeOrDirectorInd
JAMES GREENWOOD
PRESIDENT & CHIEF EXECUTIVE OFFICER40.00Yes (X)$2,534,638$0$154,112
BRENT ERICKSON
EVP, INDUSTRIAL & ENVIRONMENT40.00$968,101$0$16,476Yes (X)
THOMAS DILENGE
PRESIDENT, ADVOCACY/LAW/PUBLIC POLICY40.00$790,497$0$69,000Yes (X)
JOANNE DUNCAN
PRESIDENT, MEMBERSHIP & BU40.00$770,497$0$67,121Yes (X)
DANIEL DURHAM
EVP, HEALTH POLICY40.00$590,657$0$72,535Yes (X)
JEANNE HAGGERTY
EVP, GOVERMENT AFFAIRS & EXTERNAL RE40.00$518,700$0$49,350Yes (X)
JOSEPH DAMOND
SVP, INTERNATIONAL AFFAIRS40.00$497,231$0$75,335Yes (X)
ELIZABETH ESHAM
EVP, ECS & VP, SCIENCE & REGULATORY40.00$490,000$0$52,939Yes (X)
YVETTE WHITE-WIGGINS
SVP & CHIEF FINANCIAL OFFICER40.00Yes (X)$419,301$0$74,929
JEREMY LEVIN
CHAIR2.00Yes (X)$0$0$0Yes (X)
JOHN MARAGANORE
IMMEDIATE PAST CHAIR2.00Yes (X)$0$0$0Yes (X)
RON COHEN
IMMEDIATE PAST CHAIR (UNTIL 6/19)2.00Yes (X)$0$0$0Yes (X)
BRADFORD ZAKES
TREASURER2.00Yes (X)$0$0$0Yes (X)
JULIE GERBERDING
SECRETARY2.00Yes (X)$0$0$0Yes (X)
ABBIE CELNIKER
DIRECTOR (UNTIL 3/19)2.00$0$0$0Yes (X)
ADAM MONROE
DIRECTOR (UNTIL 10/19)2.00$0$0$0Yes (X)
ADELENE PERKINS
DIRECTOR2.00$0$0$0Yes (X)
ALAN SHAW
DIRECTOR (UNTIL 10/19)2.00$0$0$0Yes (X)
ALEXANDER HARDY
DIRECTOR2.00$0$0$0Yes (X)
ALEXANDER KARNAL
DIRECTOR2.00$0$0$0Yes (X)
ALEXANDRIA FORBES
DIRECTOR2.00$0$0$0Yes (X)
AMEET MALLIK
DIRECTOR2.00$0$0$0Yes (X)
AMIR NASHAT
DIRECTOR2.00$0$0$0Yes (X)
ANNA PROTOPAPAS
DIRECTOR (UNTIL 10/19)2.00$0$0$0Yes (X)
ANNA RATH
DIRECTOR2.00$0$0$0Yes (X)
ANNE PHILLIPS
DIRECTOR (UNTIL 1/19)2.00$0$0$0Yes (X)
ANNE WHITE
DIRECTOR2.00$0$0$0Yes (X)
BARRY FLANNELLY
DIRECTOR2.00$0$0$0Yes (X)
BASSIL DAHIYAT
DIRECTOR2.00$0$0$0Yes (X)
BERNHARDT ZEIHER
DIRECTOR2.00$0$0$0Yes (X)
BILL CAMPBELL
DIRECTOR (UNTIL 6/19)2.00$0$0$0Yes (X)
BILL SIBOLD
DIRECTOR2.00$0$0$0Yes (X)
BOB MORE
DIRECTOR2.00$0$0$0Yes (X)
BONNIE ANDERSON
DIRECTOR2.00$0$0$0Yes (X)
BRIAN BRAZEAU
DIRECTOR2.00$0$0$0Yes (X)
BRIAN THOME
DIRECTOR2.00$0$0$0Yes (X)
CARLOS PAYA
DIRECTOR (UNTIL 3/19)2.00$0$0$0Yes (X)
CEDRIC FRANCOIS
DIRECTOR2.00$0$0$0Yes (X)
CHARL VAN ZYL
DIRECTOR2.00$0$0$0Yes (X)
CHRIS STANDLEE
DIRECTOR2.00$0$0$0Yes (X)
CHRISTI SHAW
DIRECTOR2.00$0$0$0Yes (X)
CHRISTOPHE BOURDON
DIRECTOR2.00$0$0$0Yes (X)
CHRISTOPHE SCHILLING
DIRECTOR2.00$0$0$0Yes (X)
CHRISTOPHER HEALEY
DIRECTOR2.00$0$0$0Yes (X)
CLIVE MEANWELL
DIRECTOR (UNTIL 1/19)2.00$0$0$0Yes (X)
DAN MEAGHER
DIRECTOR (UNTIL 10/19)2.00$0$0$0Yes (X)
DAVID KETTNER
DIRECTOR2.00$0$0$0Yes (X)
DAVID MAIN
DIRECTOR (UNTIL 10/19)2.00$0$0$0Yes (X)
DAVID NICHOLSON
DIRECTOR2.00$0$0$0Yes (X)
DAVID STACK
DIRECTOR (UNTIL 6/19)2.00$0$0$0Yes (X)
DIANE SHANAHAN
DIRECTOR2.00$0$0$0Yes (X)
DOUG BERVEN
DIRECTOR2.00$0$0$0Yes (X)
DOUGLAS DOERFLER
DIRECTOR2.00$0$0$0Yes (X)
EDDIE SULLIVAN
DIRECTOR2.00$0$0$0Yes (X)
ELAINE SORG
DIRECTOR2.00$0$0$0Yes (X)
ELIZABETH LEWIS
DIRECTOR2.00$0$0$0Yes (X)
ERIKA SMITH
DIRECTOR2.00$0$0$0Yes (X)
FABRICE CHOURAQUI
DIRECTOR (UNTIL 10/19)2.00$0$0$0Yes (X)
GAIL MADERIS
DIRECTOR2.00$0$0$0Yes (X)
GEORGE SCANGOS
DIRECTOR2.00$0$0$0Yes (X)
GIL VAN BOKKELEN
DIRECTOR2.00$0$0$0Yes (X)
GREGG ALTON
DIRECTOR (UNTIL 10/19)2.00$0$0$0Yes (X)
H THOMAS WATKINS
DIRECTOR (UNTIL 11/19)2.00$0$0$0Yes (X)
HELEN TORLEY
DIRECTOR2.00$0$0$0Yes (X)
HOWARD ROBIN
DIRECTOR2.00$0$0$0Yes (X)
HUGH WELSH
DIRECTOR2.00$0$0$0Yes (X)
JAMES SAPIRSTEIN
DIRECTOR (UNTIL 6/19)2.00$0$0$0Yes (X)
JEAN-JACQUES BIENAIME
DIRECTOR2.00$0$0$0Yes (X)
JEFF KINDLER
DIRECTOR2.00$0$0$0Yes (X)
JEFFREY CLELAND
DIRECTOR2.00$0$0$0Yes (X)
JEFFREY MARRAZZO
DIRECTOR2.00$0$0$0Yes (X)
JENNIFER HOLMGREN
DIRECTOR2.00$0$0$0Yes (X)
JENNIFER TAUBERT
DIRECTOR2.00$0$0$0Yes (X)
JILL ZULLO
DIRECTOR2.00$0$0$0Yes (X)
JOHN CROWLEY
DIRECTOR2.00$0$0$0Yes (X)
JOHN LEPORE
DIRECTOR2.00$0$0$0Yes (X)
JOHN MELO
DIRECTOR2.00$0$0$0Yes (X)
JOHN OYLER
DIRECTOR2.00$0$0$0Yes (X)
JOHN YOUNG
DIRECTOR2.00$0$0$0Yes (X)
JOSEPH LAROSA
DIRECTOR2.00$0$0$0Yes (X)
JOSHUA OFMAN
DIRECTOR (UNTIL 6/19)2.00$0$0$0Yes (X)
JULIA OWENS
DIRECTOR2.00$0$0$0Yes (X)
JUSTIN GOVER
DIRECTOR2.00$0$0$0Yes (X)
KARSTEN TEMME
DIRECTOR2.00$0$0$0Yes (X)
KATRINE BOSLEY
DIRECTOR (UNTIL 6/19)2.00$0$0$0Yes (X)
KENNETH MOCH
DIRECTOR2.00$0$0$0Yes (X)
KEVIN GORMAN
DIRECTOR2.00$0$0$0Yes (X)
KIRAN MAZUMDAR-SHAW
DIRECTOR (UNTIL 1/19)2.00$0$0$0Yes (X)
LAURA BEREZIN
DIRECTOR2.00$0$0$0Yes (X)
LONNIE MOULDER
DIRECTOR (UNTIL 1/19)2.00$0$0$0Yes (X)
MARK DROZDOWSKI
DIRECTOR2.00$0$0$0Yes (X)
MARK ENYEDY
DIRECTOR2.00$0$0$0Yes (X)
MARK PLATT
DIRECTOR2.00$0$0$0Yes (X)
MARK PRUZANSKI
DIRECTOR2.00$0$0$0Yes (X)
MARK TIMNEY
DIRECTOR2.00$0$0$0Yes (X)
MARK TRUDEAU
DIRECTOR2.00$0$0$0Yes (X)
MARTIN BABLER
DIRECTOR2.00$0$0$0Yes (X)
MEENU CHHABRA
DIRECTOR2.00$0$0$0Yes (X)
MICHAEL MORRISSEY
DIRECTOR2.00$0$0$0Yes (X)
MICHAEL NARACHI
DIRECTOR2.00$0$0$0Yes (X)
MICHAEL RAAB
DIRECTOR2.00$0$0$0Yes (X)
MICHAEL RYAN
DIRECTOR2.00$0$0$0Yes (X)
NANCY SIMONIAN
DIRECTOR2.00$0$0$0Yes (X)
NICK LESCHLY
DIRECTOR2.00$0$0$0Yes (X)
OLIVER WALKER
DIRECTOR2.00$0$0$0Yes (X)
PAIGE MAHANEY
DIRECTOR2.00$0$0$0Yes (X)
PATRICK GRUBER
DIRECTOR2.00$0$0$0Yes (X)
PAUL HASTINGS
DIRECTOR2.00$0$0$0Yes (X)
PAUL MCKENZIE
DIRECTOR (UNTIL 6/19)2.00$0$0$0Yes (X)
PERRY STERNBERG
DIRECTOR (UNTIL 1/19)2.00$0$0$0Yes (X)
PHILIP MILLER
DIRECTOR2.00$0$0$0Yes (X)
RACHEL KING
DIRECTOR2.00$0$0$0Yes (X)
RICHARD PAULSON
DIRECTOR2.00$0$0$0Yes (X)
RICHARD POPS
DIRECTOR2.00$0$0$0Yes (X)
RICK TURNER
DIRECTOR2.00$0$0$0Yes (X)
RICK WINNINGHAM
DIRECTOR2.00$0$0$0Yes (X)
ROBERT WALSH
DIRECTOR2.00$0$0$0Yes (X)
ROBERT WILLS
DIRECTOR2.00$0$0$0Yes (X)
ROGER WYSE
DIRECTOR2.00$0$0$0Yes (X)
RONALD STOTISH
DIRECTOR (UNTIL 6/19)2.00$0$0$0Yes (X)
RUSSELL HERNDON
DIRECTOR2.00$0$0$0Yes (X)
SANDY MACRAE
DIRECTOR2.00$0$0$0Yes (X)
SCOTT HOLMSTROM
DIRECTOR2.00$0$0$0Yes (X)
SCOTT KOENIG
DIRECTOR2.00$0$0$0Yes (X)
SEBASTIAN GUTH
DIRECTOR2.00$0$0$0Yes (X)
SHAJI PROCIDA
DIRECTOR2.00$0$0$0Yes (X)
SHARON MATES
DIRECTOR2.00$0$0$0Yes (X)
SHEILA GUJRATHI
DIRECTOR2.00$0$0$0Yes (X)
STEVE ALBERS
DIRECTOR2.00$0$0$0Yes (X)
STEVEN MENTO
DIRECTOR (UNTIL 8/19)2.00$0$0$0Yes (X)
STUART ARBUCKLE
DIRECTOR2.00$0$0$0Yes (X)
SUE WASHER
DIRECTOR2.00$0$0$0Yes (X)
SYLVIA WULF
DIRECTOR2.00$0$0$0Yes (X)
TAMMY LEE
DIRECTOR (UNTIL 7/19)2.00$0$0$0Yes (X)
TED LOVE
DIRECTOR2.00$0$0$0Yes (X)
TERRIE CURRAN
DIRECTOR (UNTIL 12/19)2.00$0$0$0Yes (X)
THOMAS WIGGANS
DIRECTOR2.00$0$0$0Yes (X)
TIMOTHY WALBERT
DIRECTOR2.00$0$0$0Yes (X)
WILLIAM FITZSIMMONS
DIRECTOR (UNTIL 3/19)2.00$0$0$0Yes (X)
WILLIAM NEWELL
DIRECTOR2.00$0$0$0Yes (X)
FieldValueIRS element (for citing)
Total Reportable Comp From Org$7,579,622TotalReportableCompFromOrgAmt
Tot Reportable Comp Rltd Org$0TotReportableCompRltdOrgAmt
Total Other Compensation$631,797TotalOtherCompensationAmt
Indiv Rcvd Greater Than100 K98IndivRcvdGreaterThan100KCnt
Former Ofcr Employees Listed0FormerOfcrEmployeesListedInd
Total Comp Greater Than150 KYes (1)TotalCompGreaterThan150KInd
Compensation From Other Srcs0CompensationFromOtherSrcsInd

Contractor Compensation ContractorCompensationGrp (5 entries)

Address Line1ContractorAddress/USAddress/AddressLine1TxtCityContractorAddress/USAddress/CityNmState AbbreviationContractorAddress/USAddress/StateAbbreviationCdZIPContractorAddress/USAddress/ZIPCdServicesServicesDescCompensationCompensationAmt
FREEMAN EXPOSITIONS
PO BOX 660613DALLASTX75266CONVENTION & CONFERENCES CONTRACTOR$2,785,194
SUBJECT MATTER
1201 NEW YORK AVENUE NWWASHINGTONDC20005CONSULTING SERVICES$1,841,510
DANIEL J EDELMAN INC
200 E RANDOLPH DRIVE SUITE 6300CHICAGOIL60601CONSULTING SERVICES$1,834,164
ARAMARK
1101 ARCH STREETPHILADELPHIAPA19107CONVENTION CENTER RENTAL$1,321,436
THE HERALD GROUP LLC
1800 M STREET NW SUITE 450 SOUTHWASHINGTONDC20036CONVENTION CENTER RENTAL$1,200,000
FieldValueIRS element (for citing)
Cntrct Rcvd Greater Than100 K111CntrctRcvdGreaterThan100KCnt

Program Service Revenue ProgramServiceRevenueGrp (5 entries)

DescDescBusinessBusinessCdTotal Revenue ColumnTotalRevenueColumnAmtRelated Or Exempt Func IncomeRelatedOrExemptFuncIncomeAmtUnrelated Business RevenueUnrelatedBusinessRevenueAmt
CONFERENCE/MEETING REVENUE541800$41,042,359$40,591,159$451,200
MEMBERSHIP DUES900099$29,773,139$29,773,139
EPF MEMBER SUPPORT900099$3,791,882$3,791,882
LEGAL & POLICY SUPPORT900099$764,449$764,449
ALLIANCE/OUTREACH SUPPORT900099$37,000$37,000

Total Oth Program Service Rev TotalOthProgramServiceRevGrp

FieldValueIRS element (for citing)
Total Revenue Column$28,485TotalRevenueColumnAmt
Related Or Exempt Func Income$28,485RelatedOrExemptFuncIncomeAmt
FieldValueIRS element (for citing)
Total Program Service Revenue$75,437,314TotalProgramServiceRevenueAmt

Investment Income InvestmentIncomeGrp

FieldValueIRS element (for citing)
Total Revenue Column$2,573,466TotalRevenueColumnAmt
Exclusion$2,573,466ExclusionAmt

Royalties Revenue RoyaltiesRevenueGrp

FieldValueIRS element (for citing)
Total Revenue Column$13,788,489TotalRevenueColumnAmt
Unrelated Business Revenue$549,842UnrelatedBusinessRevenueAmt
Exclusion$13,238,647ExclusionAmt

Gross Rents GrossRentsGrp

FieldValueIRS element (for citing)
Real$8,800RealAmt

Less Rental Expenses LessRentalExpensesGrp

FieldValueIRS element (for citing)
Real$8,800RealAmt

Rental Income Or Loss RentalIncomeOrLossGrp

FieldValueIRS element (for citing)
Real$0RealAmt

Gross Amount Sales Assets GrossAmountSalesAssetsGrp

FieldValueIRS element (for citing)
Securities$4,606,597SecuritiesAmt

Less Cost Oth Basis Sales Expnss LessCostOthBasisSalesExpnssGrp

FieldValueIRS element (for citing)
Securities$4,011,484SecuritiesAmt

Gain Or Loss GainOrLossGrp

FieldValueIRS element (for citing)
Securities$595,113SecuritiesAmt

Net Gain Or Loss Investments NetGainOrLossInvestmentsGrp

FieldValueIRS element (for citing)
Total Revenue Column$595,113TotalRevenueColumnAmt
Exclusion$595,113ExclusionAmt

Other Revenue Misc OtherRevenueMiscGrp

FieldValueIRS element (for citing)
DescBIONEWS ADS INCOMEDesc
Business541800BusinessCd
Total Revenue Column$7,500TotalRevenueColumnAmt
Unrelated Business Revenue$7,500UnrelatedBusinessRevenueAmt

Miscellaneous Revenue MiscellaneousRevenueGrp

FieldValueIRS element (for citing)
Total Revenue Column$35,387TotalRevenueColumnAmt
Exclusion$35,387ExclusionAmt
FieldValueIRS element (for citing)
Other Revenue Total$42,887OtherRevenueTotalAmt

Total Revenue TotalRevenueGrp

FieldValueIRS element (for citing)
Total Revenue Column$92,437,269TotalRevenueColumnAmt
Related Or Exempt Func Income$74,986,114RelatedOrExemptFuncIncomeAmt
Unrelated Business Revenue$1,008,542UnrelatedBusinessRevenueAmt
Exclusion$16,442,613ExclusionAmt
FieldValueIRS element (for citing)
Info In Schedule O Part IXYes (X)InfoInScheduleOPartIXInd

Grants To Domestic Orgs GrantsToDomesticOrgsGrp

FieldValueIRS element (for citing)
Total$3,162,700TotalAmt

Comp Current Ofcr Directors CompCurrentOfcrDirectorsGrp

FieldValueIRS element (for citing)
Total$4,880,095TotalAmt

Other Salaries And Wages OtherSalariesAndWagesGrp

FieldValueIRS element (for citing)
Total$26,392,429TotalAmt

Pension Plan Contributions PensionPlanContributionsGrp

FieldValueIRS element (for citing)
Total$2,320,083TotalAmt

Other Employee Benefits OtherEmployeeBenefitsGrp

FieldValueIRS element (for citing)
Total$4,086,479TotalAmt

Payroll Taxes PayrollTaxesGrp

FieldValueIRS element (for citing)
Total$1,624,771TotalAmt

Fees For Services Legal FeesForServicesLegalGrp

FieldValueIRS element (for citing)
Total$249,312TotalAmt

Fees For Services Accounting FeesForServicesAccountingGrp

FieldValueIRS element (for citing)
Total$77,016TotalAmt

Fees For Services Lobbying FeesForServicesLobbyingGrp

FieldValueIRS element (for citing)
Total$4,574,874TotalAmt

Fees For Srvc Invst Mgmnt Fees FeesForSrvcInvstMgmntFeesGrp

FieldValueIRS element (for citing)
Total$65,114TotalAmt

Fees For Services Other FeesForServicesOtherGrp

FieldValueIRS element (for citing)
Total$15,240,690TotalAmt

Advertising AdvertisingGrp

FieldValueIRS element (for citing)
Total$407,570TotalAmt

Office Expenses OfficeExpensesGrp

FieldValueIRS element (for citing)
Total$595,204TotalAmt

Information Technology InformationTechnologyGrp

FieldValueIRS element (for citing)
Total$1,130,035TotalAmt

Occupancy OccupancyGrp

FieldValueIRS element (for citing)
Total$3,908,026TotalAmt

Travel TravelGrp

FieldValueIRS element (for citing)
Total$1,838,936TotalAmt

Conferences Meetings ConferencesMeetingsGrp

FieldValueIRS element (for citing)
Total$16,979,149TotalAmt

Interest InterestGrp

FieldValueIRS element (for citing)
Total$10,612TotalAmt

Payments To Affiliates PaymentsToAffiliatesGrp

FieldValueIRS element (for citing)
Total$5,614,298TotalAmt

Depreciation Depletion DepreciationDepletionGrp

FieldValueIRS element (for citing)
Total$541,255TotalAmt

Insurance InsuranceGrp

FieldValueIRS element (for citing)
Total$131,633TotalAmt

Other Expenses OtherExpensesGrp (4 entries)

DescDescTotalTotalAmt
DUES & SUBSCRIPTIONS$1,213,530
TAXES PAID$544,807
OUTREACH$343,241
BIO LEGISLATIVE DAY/FLY$219,693

All Other Expenses AllOtherExpensesGrp

FieldValueIRS element (for citing)
Total$40,000TotalAmt

Total Functional Expenses TotalFunctionalExpensesGrp

FieldValueIRS element (for citing)
Total$96,191,552TotalAmt

Cash Non Interest Bearing CashNonInterestBearingGrp

FieldValueIRS element (for citing)
BOY$6,430,187BOYAmt
EOY$3,112,278EOYAmt

Savings And Temp Cash Invst SavingsAndTempCashInvstGrp

FieldValueIRS element (for citing)
BOY$3,364,536BOYAmt
EOY$1,164,890EOYAmt

Accounts Receivable AccountsReceivableGrp

FieldValueIRS element (for citing)
BOY$4,302,636BOYAmt
EOY$4,901,799EOYAmt

Prepaid Expenses Defrd Charges PrepaidExpensesDefrdChargesGrp

FieldValueIRS element (for citing)
BOY$2,635,707BOYAmt
EOY$2,684,754EOYAmt
FieldValueIRS element (for citing)
Land Bldg Equip Cost Or Other Bss$8,263,569LandBldgEquipCostOrOtherBssAmt
Land Bldg Equip Accum Deprec$6,938,698LandBldgEquipAccumDeprecAmt

Land Bldg Equip Basis Net LandBldgEquipBasisNetGrp

FieldValueIRS element (for citing)
BOY$1,088,918BOYAmt
EOY$1,324,871EOYAmt

Investments Pub Traded Sec InvestmentsPubTradedSecGrp

FieldValueIRS element (for citing)
BOY$61,118,069BOYAmt
EOY$71,179,512EOYAmt

Total Assets TotalAssetsGrp

FieldValueIRS element (for citing)
BOY$78,940,053BOYAmt
EOY$84,368,104EOYAmt

Accounts Payable Accr Expnss AccountsPayableAccrExpnssGrp

FieldValueIRS element (for citing)
BOY$18,759,698BOYAmt
EOY$18,918,891EOYAmt

Deferred Revenue DeferredRevenueGrp

FieldValueIRS element (for citing)
BOY$15,113,063BOYAmt
EOY$15,579,354EOYAmt

Other Liabilities OtherLiabilitiesGrp

FieldValueIRS element (for citing)
BOY$3,095,895BOYAmt
EOY$2,235,117EOYAmt

Total Liabilities TotalLiabilitiesGrp

FieldValueIRS element (for citing)
BOY$36,968,656BOYAmt
EOY$36,733,362EOYAmt
FieldValueIRS element (for citing)
Organization Follows FASB117Yes (X)OrganizationFollowsFASB117Ind

No Donor Restriction Net Assets NoDonorRestrictionNetAssetsGrp

FieldValueIRS element (for citing)
BOY$41,971,397BOYAmt
EOY$47,634,742EOYAmt

Total Net Assets Fund Balance TotalNetAssetsFundBalanceGrp

FieldValueIRS element (for citing)
BOY$41,971,397BOYAmt
EOY$47,634,742EOYAmt

Tot Liab Net Assets Fund Balance TotLiabNetAssetsFundBalanceGrp

FieldValueIRS element (for citing)
BOY$78,940,053BOYAmt
EOY$84,368,104EOYAmt
FieldValueIRS element (for citing)
Info In Schedule O Part XIYes (X)InfoInScheduleOPartXIInd
Reconcilation Revenue Expnss-$3,754,283ReconcilationRevenueExpnssAmt
Net Unrlzd Gains Losses Invst$9,289,428NetUnrlzdGainsLossesInvstAmt
Other Changes In Net Assets$128,200OtherChangesInNetAssetsAmt
Method Of Accounting AccrualYes (X)MethodOfAccountingAccrualInd
Accountant Compile Or Review0AccountantCompileOrReviewInd
FS AuditedYes (1)FSAuditedInd

FS Audited Basis FSAuditedBasisGrp

FieldValueIRS element (for citing)
Separate Basis Fincl StmtYes (X)SeparateBasisFinclStmtInd
FieldValueIRS element (for citing)
Audit CommitteeYes (1)AuditCommitteeInd
Federal Grant Audit Required0FederalGrantAuditRequiredInd

Schedule C IRS990ScheduleC

FieldValueIRS element (for citing)
Substantially All Dues Nonded0SubstantiallyAllDuesNondedInd
Only In House Lobbying0OnlyInHouseLobbyingInd
Agree Carryover Prior YearYes (1)AgreeCarryoverPriorYearInd
Dues Assessments$29,773,139DuesAssessmentsAmt
Non Deductible Lbbyng Pltcl CY$12,210,000NonDeductibleLbbyngPltclCYAmt
Non Ded Lbbyng Pltcl Cyov$263,328NonDedLbbyngPltclCyovAmt
Non Deductible Lbbyng Pltcl Tot$12,473,328NonDeductibleLbbyngPltclTotAmt
Aggregate Reported Dues Ntc$12,206,987AggregateReportedDuesNtcAmt
Carried Over$266,341CarriedOverAmt

Schedule D IRS990ScheduleD

Leasehold Improvements LeaseholdImprovementsGrp

FieldValueIRS element (for citing)
Other Cost Or Other Basis$6,258,352OtherCostOrOtherBasisAmt
Depreciation$5,950,712DepreciationAmt
Book Value$307,640BookValueAmt

Equipment EquipmentGrp

FieldValueIRS element (for citing)
Other Cost Or Other Basis$276,745OtherCostOrOtherBasisAmt
Depreciation$200,020DepreciationAmt
Book Value$76,725BookValueAmt

Other Land Buildings OtherLandBuildingsGrp

FieldValueIRS element (for citing)
Other Cost Or Other Basis$1,728,472OtherCostOrOtherBasisAmt
Depreciation$787,966DepreciationAmt
Book Value$940,506BookValueAmt
FieldValueIRS element (for citing)
Total Book Value Land Buildings$1,324,871TotalBookValueLandBuildingsAmt

Other Liabilities Org OtherLiabilitiesOrgGrp (2 entries)

DescDescAmtAmt
CAPITAL LEASE OBLIGATION$82,392
DEFERRED RENT$2,152,725
FieldValueIRS element (for citing)
Total Liability$2,235,117TotalLiabilityAmt
Total Rev Etc Audited Fincl Stmt$103,696,240TotalRevEtcAuditedFinclStmtAmt
Net Unrealized Gains Invst$9,289,428NetUnrealizedGainsInvstAmt
Other Revenue$2,025,857OtherRevenueAmt
Revenue Not Reported$11,315,285RevenueNotReportedAmt
Revenue Subtotal$92,380,955RevenueSubtotalAmt
Investment Expenses Not Incld$65,114InvestmentExpensesNotIncldAmt
Other Revenues Not Included-$8,800OtherRevenuesNotIncludedAmt
Revenue Not Reported Fincl Stmt$56,314RevenueNotReportedFinclStmtAmt
Total Revenue Per Form990$92,437,269TotalRevenuePerForm990Amt
Tot Expns Etc Audited Fincl Stmt$98,032,895TotExpnsEtcAuditedFinclStmtAmt
Other Expenses Included$2,004,657OtherExpensesIncludedAmt
Expenses Not Reported$2,004,657ExpensesNotReportedAmt
Expenses Subtotal$96,028,238ExpensesSubtotalAmt
Investment Expenses Not Incld2$65,114InvestmentExpensesNotIncld2Amt
Other Expenses Not Included$98,200OtherExpensesNotIncludedAmt
Expenses Not Rpt Fincl Stmt$163,314ExpensesNotRptFinclStmtAmt
Total Expenses Per Form990$96,191,552TotalExpensesPerForm990Amt

Supplemental Information Detail SupplementalInformationDetail (4 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
PART XI, LINE 2D - OTHER ADJUSTMENTS:BIOSIMILARS REVENUE 80,000. FGR SPECIAL INITIATIVES REVENUE 913,306. CBI LOBBYING FUND 1,032,551.
PART XI, LINE 4B - OTHER ADJUSTMENTS:RENTAL EXPENSES -8,800.
PART XII, LINE 2D - OTHER ADJUSTMENTS:FOOD & AG LEGAL FUND EXPENSES BIOSIMILAR EXPENSES 80,000. FGR SPECIAL INITIATIVE EXPENSES 913,306. FOOD & AG SGR FUND 1,002,551. RENTAL EXPENSES 8,800.
PART XII, LINE 4B - OTHER ADJUSTMENTS:DEFERRED SPONSORSHIP EXPENSE 98,200.

Schedule F IRS990ScheduleF

FieldValueIRS element (for citing)
Grant Records MaintainedYes (1)GrantRecordsMaintainedInd

Account Activities Outside US AccountActivitiesOutsideUSGrp (7 entries)

RegionRegionTxtOfficesOfficesCntEmployeeEmployeeCntType Of Activities ConductedTypeOfActivitiesConductedTxtSpecific Services ProvidedSpecificServicesProvidedTxtRegion Total ExpendituresRegionTotalExpendituresAmt
EAST ASIA AND THE PACIFIC - AUSTRALIA, BRUNEI, BURMA, CAMBODIA,03PROGRAM SERVICESCONFERENCES, ADVOCACY$492,487
EUROPE (INCLUDING ICELAND & GREENLAND) - ALBANIA, ANDORRA, AUSTRIA, BELGIUM02PROGRAM SERVICESCONFERENCES, ADVOCACY AND EDUCATION$301,291
MIDDLE EAST AND NORTH AFRICA - ALGERIA, BAHRAIN, DJIBOUTI, EGYPT,01PROGRAM SERVICESADVOCACY$10,073
NORTH AMERICA - CANADA AND MEXICO, BUT NOT THE UNITED STATES12PROGRAM SERVICESCONFERENCES, ADVOCACY$4,664
SOUTH AMERICA - ARGENTINA, BOLIVIA, BRAZIL, CHILE, COLUMBIA, ECUADOR,01PROGRAM SERVICESADVOCACY$121,670
SOUTH ASIA - AFGHANISTAN, BANGLADESH, BHUTAN, INDIA, MALDIVES, NEPAL,00PROGRAM SERVICESADVOCACY$22,365
SUB-SAHARAN AFRICA - ANGOLA, BENIN, BOTSWANA, BURKINA FASO,00PROGRAM SERVICESADVOCACY$11,898
FieldValueIRS element (for citing)
Subtotal Offices1SubtotalOfficesCnt
Subtotal Employees9SubtotalEmployeesCnt
Continuation Total Office0ContinuationTotalOfficeCnt
Continuation Total Employee0ContinuationTotalEmployeeCnt
Total Office1TotalOfficeCnt
Total Employee9TotalEmployeeCnt
Subtotal Spent$964,448SubtotalSpentAmt
Continuation Spent$0ContinuationSpentAmt
Total Spent$964,448TotalSpentAmt
Transfer To Foreign Corp0TransferToForeignCorpInd
Interest In Foreign Trust0InterestInForeignTrustInd
Foreign Corp Ownership0ForeignCorpOwnershipInd
Passive Foreign Investmest Co0PassiveForeignInvestmestCoInd
Foreign Partnership0ForeignPartnershipInd
Boycott Countries0BoycottCountriesInd

Supplemental Information Detail SupplementalInformationDetail (2 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
PART I, LINE 2:THE ORGANIZATION HAS SUPPORTING DOCUMENTATION FOR THE AMOUNT THAT IS INVOICED FROM THE COMPANIES.
PART III ACCOUNTING METHOD:

Schedule I IRS990ScheduleI

FieldValueIRS element (for citing)
Grant Records MaintainedYes (1)GrantRecordsMaintainedInd

Recipient Table RecipientTable (74 entries)

Address Line1USAddress/AddressLine1TxtCityUSAddress/CityNmState AbbreviationUSAddress/StateAbbreviationCdZIPUSAddress/ZIPCdRecipient EINRecipientEINIRC SectionIRCSectionDescCash GrantCashGrantAmtPurpose Of GrantPurposeOfGrantTxtAddress Line2USAddress/AddressLine2Txt
ADAP ADVOCACY ASSOCIATION
PO BOX 846NAGS HEADNC27959260482120501(C)(3)$6,000SCHOLARSHIP
ALLIANCE FOR AGING RESEARCH
1700 K STREET NW SUITE 740WASHINGTONDC20006541379174501(C)(3)$15,000SPONSORSHIP
ALLIANCE TO PROTECT MEDICAL INNOVATION
1220 L ST NW SUITE 100 488WASHINGTONDC20005831354631501(C)(4)$160,000CONTRIBUTION
AMERICAN ACTION FORUM
1747 PENNSYLVANIA AVE NW 5TH FLOORWASHINGTONDC20006270567765501(C)(3)$75,000CONTRIBUTION
AMERICAN CANCER SOCIETY ACTION NETWORK INC
555 11TH STREET SUITE 300WASHINGTONDC20004522340031501(C)(4)$10,000SPONSORSHIP
AMERICAN CANCER SOCIETY ACTION NETWORK INC
555 11TH STREET SUITE 300WASHINGTONDC20004522340031501(C)(4)$25,000GENERAL SUPPORT
AMERICAN ENTERPRISE INSTITUTE FOR PUBLIC POLICY RESEARCH
1789 MASSACHUSETTS AVENUE NWWASHINGTONDC20036530218495501(C)(3)$30,000GENERAL SUPPORT
ARIZONA BIOINDUSTRY ASSOCIATION
107 S SOUTHGATE DRIVECHANDLERAZ85226860938465501(C)(6)$15,000SPONSORSHIP
ARTHRITIS FOUNDATION INC
1355 PEACHTREE ST 600ATLANTAGA30309581341679501(C)(3)$15,000SPONSORSHIP
ARTHRITIS FOUNDATION INC
1355 PEACHTREE ST 600ATLANTAGA30309581341679501(C)(3)$47,000GENERAL SUPPORT
ASSOCIATION OF AMERICAN VETERINARY MEDICAL COLLEGES
655 K ST NW SUITE 725WASHINGTONDC20001366144553501(C)(3)$25,000SPONSORSHIP
AUTOIMMUNE DISEASE ASSOCIATION
22100 GRATIOT AVEEASTPOINTEMI480212227383027574501(C)(3)$10,000GENERAL SUPPORT
BIO FLORIDA
6742 FOREST HILL BLVD SUITE 256WEST PALM BEACHFL33413593436638501(C)(6)$5,500SPONSORSHIP
BIO NEBRASKA LIFE SCIENCES ASSOCIATION
PO BOX 24802OMAHANE68124202214508501(C)(6)$6,000SPONSORSHIP
BIONJ INC
1255 WHITEHORSE-MERCERVILLE RDTRENTONNJ08619223284393501(C)(6)$50,000SPONSORSHIPBUILDING B - SUITE 514
BIOOHIO
1275 KINNEAR RDCOLUMBUSOH43212341577705501(C)(3)$10,000SPONSORSHIP
CALIFORNIA LIFE SCIENCES ASSOCIATION
9191 TOWNE CENTRE DRIVE SUITE 450SAN DIEGOCA92122473226523501(C)(6)$300,000GENERAL SUPPORT
CANCER SUPPORT COMMUNITY
734 15TH STREET NW SUITE 300WASHINGTONDC20005954163931501(C)(3)$25,000GENERAL SUPPORT
CAPITAL CLUBHOUSE INC
80 M ST SE 1ST FLOORWASHINGTONDC20003454366185501(C)(3)$10,000SPONSORSHIP
CENTER FOR FOOD INTEGRITY
2900 NE BROOKTREE LANE SUITE 200GLADSTONEMO64119204662713501(C)(4)$25,000GENERAL SUPPORT
CENTER FOR MEDICINE IN THE PUBLIC INTEREST
757 THIRD AVENUE 20TH FLOORNEW YORKNY10017204321812501(C)(3)$25,000GENERAL SUPPORT
COLORADO BIOSCIENCE ASSOCIATION
600 GRANT STREET SUITE 306DENVERCO80203841363258501(C)(6)$10,000SPONSORSHIP
CYSTIC FIBROSIS FOUNDATION
4550 MONTGOMERY AVENUE SUITE 350NBETHESDAMD20814131930701501(C)(3)$7,500SPONSORSHIP
DELAWARE BIOSCIENCE ASSOCIATION
1 INNOVATION WAY SUITE 300NEWARKDE19711204147195501(C)(6)$15,000SPONSORSHIP
DEMOCRATIC GOVERNORS ASSOCIATION
1401 K ST NW SUITE 200WASHINGTONDC20005521304889N/A$25,000CONTRIBUTION
EPILEPSY FOUNDATION
8301 PROFESSIONAL PLACE EAST SUITELANDOVERMD207852353520856660501(C)(3)$15,000GENERAL SUPPORT200
EVERYLIFE FOUNDATION FOR RARE DISEASES
1012 14TH ST NW SUITE 500WASHINGTONDC20005264614274501(C)(3)$10,000SPONSORSHIP
GLOBAL DOWN SYNDROME FOUNDATION
3239 E 2ND AVEDENVERCO80206264431001501(C)(3)$6,000SPONSORSHIP
GLOBAL GENES
28 ARGONAUT SUITE 150ALISO VIEJOCA92656263331487501(C)(3)$10,000GENERAL SUPPORT
HAWAII FARM BUREAU FEDERATION
PO BOX 253KUNIAHI96759990073460501(C)(5)$22,500GENERAL SUPPORT
HEALTHCARE READY
1325 G ST NW SUITE 500WASHINGTONDC20005463134601501(C)(3)$10,000CONTRIBUTION
HEALTHY WOMEN
1 HARDING RD SUITE 102ARED BANKNJ07701521624846501(C)(3)$20,000SPONSORSHIP
INFORMATION TECHNOLOGY AND INNOVATION FOUNDATION
1101 K ST NW SUITE 610WASHINGTONDC20005204403497501(C)(3)$60,000GENERAL SUPPORT
INSTITUTE FOR PATIENT ACCESS
PO BOX 670BETTENDORFIA52722453456087501(C)(3)$30,000GENERAL SUPPORT
INSTITUTE FOR POLICY INNOVATION
1320 GREENWAY DR SUITE 820IRVINGTX75038752158093501(C)(3)$15,000GENERAL SUPPORT
INSTITUTE ON SCIENCE FOR GLOBAL POLICY
13630 E SAHUARO SUNSET RDTUCSONAZ85749453998749501(C)(3)$20,000GENERAL SUPPORT
IOWA BIOTECH ASSOCIATION
900 E DES MOINES STDES MOINESIA50309391885797501(C)(6)$15,000GENERAL SUPPORT
JDRF INTERNATIONAL
1400 K STREET NW SUITE 725WASHINGTONDC20005231907729501(C)(3)$10,000SPONSORSHIP
KEYSTONE POLICY CENTER
1628 SAINTS JOHN ROADKEYSTONECO80435840688506501(C)(3)$20,000GENERAL SUPPORT
LEUKEMIA & LYMPHOMA SOCIETY
3601 EISENHOWER AVENUE SUITE 450ALEXANDRIAVA22304135644916501(C)(3)$10,000SPONSORSHIP
LOUISIANABIO
1441 CANAL STREETNEW ORLEANSLA70112273567932N/A$20,000GENERAL SUPPORT
LUNGEVITY FOUNDATION
228 S WABASH AVE SUITE 700CHICAGOIL60604364433410501(C)(3)$20,000GENERAL SUPPORT
LUPUS FOUNDATION OF AMERICA INC
2121 K STREET NW SUITE 200WASHINGTONDC20037431131436501(C)(3)$309,000GENERAL SUPPORT
MASSACHUSETTS BIOTECHNOLOGY COUNCIL
300 TECHNOLOGY SQUARE 8TH FLOORCAMBRIDGEMA02139222693047501(C)(6)$7,500SPONSORSHIP
MONTANA BIOSCIENCE ALLIANCE
P O BOX 1773BILLINGSMT59103201647600501(C)(6)$15,000GENERAL SUPPORT
NATIONAL ASSOCIATION OF STATE DEPARTMENT OF AGRICULTURE (NASDA)
4350 N FAIRFAX DR SUITE 910ARLINGTONVA22203520845105501(C)(6)$12,500SPONSORSHIP
NATIONAL BLACK CHURCH INITIATIVE
POBOX 65177WASHINGTONDC20035522169774N/A$25,000GENERAL SUPPORT
NATIONAL COALITION FOR CANCER SURVIVORSHIP
8455 COLESVILLE ROAD SUITE 930SILVER SPRINGMD20910850357897501(C)(3)$10,000SPONSORSHIP
NATIONAL CONFERENCE OF STATE LEGISLATURES
7700 EAST FIRST PLACEDENVERCO80230840772595N/A$22,000SPONSORSHIP
NATIONAL FARMERS UNION
20 F STREET NW 300WASHINGTONDC20001840200555501(C)(3)$10,000SPONSORSHIP
NATIONAL HEALTH COUNCIL
1730 M STREET NW SUITE 500WASHINGTONDC20036131624107501(C)(3)$15,000SPONSORSHIP
NATIONAL PSORIASIS FOUNDATION
6600 SW 92ND AVE SUITE 300PORTLANDOR97223930571472501(C)(3)$15,000GENERAL SUPPORT
NCSL FOUNDATION FOR STATE LEGISLATURES
7700 EAST FIRST PLACEDENVERCO80230742232576501(C)(3)$7,500SPONSORSHIP
NEW YORK BIOTECHNOLOGY ASSOCIATION
25 HEALTH SCIENCES DR SUITE 203STONY BROOKNY11790113026494501(C)(6)$25,000SPONSORSHIP
ONE NATION
45 N HILL DRIVE SUITE 100WARRENTONVA20186271937961501(C)(4)$250,000GENERAL SUPPORT
OREGON BIOSCIENCE ASSOCIATION
2828 SW CORBETT AVE SUITE 115PORTLANDOR97201931009329501(C)(6)$20,000SPONSORSHIP
OREGON BIOSCIENCE ASSOCIATION
2828 SW CORBETT AVE SUITE 115PORTLANDOR97201931009329501(C)(6)$10,000GENERAL SUPPORT
ORRIN G HATCH FOUNDATION
411 E SOUTH TEMPLESALT LAKE CITYUT84111474823732501(C)(3)$25,000SPONSORSHIP
PERSONALIZED MEDICINE COALITION
1225 NEW YORK AVE SUITE 450WASHINGTONDC20005542134884501(C)(3)$20,000SPONSORSHIP
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
950 F STREET NW SUITE 300WASHINGTONDC20004530241211501(C)(6)$40,000GENERAL SUPPORT
PREVENT CANCER FOUNDATION
1600 DUKE ST SUITE 500ALEXANDRIAVA22314521429544501(C)(3)$7,000SPONSORSHIP
RARE ACCESS ACTION PROJECT
PO BOX 2756PURCELLVILLEVA20134824433613501(C)(4)$10,000GENERAL SUPPORT
RI BIO
PO BOX 5680 53 BROAD STPROVIDENCERI02903462858053501(C)(6)$6,000SPONSORSHIP
SICK CELLS
4512 RIVER DRIVELISLEIL60532813481633501(C)(3)$10,000SPONSORSHIP
SOCIETY FOR WOMEN'S HEALTH RESEARCH
1025 CONNECTICUT AVE NW SUITE 601WASHINGTONDC20036521694732501(C)(3)$15,000SPONSORSHIP
STATE AGRICULTURE AND RURAL LEADERS
21547 HWY 527ALDENIA50006204400600501(C)(3)$7,500SPONSORSHIP
STATE OF REFORM
19101 36TH AVE W 203LYNNWOODWA98036201502691N/A$8,200SPONSORSHIP
THE AIDS INSTITUTE
17 DAVIS BLVD SUITE 403TAMPAFL33606650380952501(C)(3)$15,000GENERAL SUPPORT
THE GALIEN FOUNDATION INC
99 JOHN STREET SUITE 2502NEW YORKNY10038264549935501(C)(3)$15,000SPONSORSHIP
TRUSTEES OF TUFTS COLLEGE
75 KNEELAND ST SUITE 1100 TUFTSBOSTONMA02111042103634501(C)(3)$12,000SPONSORSHIPUNIVERSITY
US - INDIA STRATEGIC PARTNERSHIP INC
2550 M STREET NWWASHINGTONDC20037822265517501(C)(6)$15,000SPONSORSHIP
US CHAMBER OF COMMERCE
1615 H STREET NW PO BOX 1200WASHINGTONDC20062530045720501(C)(6)$875,000GENERAL SUPPORT
US CHAMBER OF COMMERCE
1615 H STREET NW PO BOX 1200WASHINGTONDC20062530045720501(C)(6)$50,000CONTRIBUTION
VIRGINIA BIOTECHNOLOGY ASSOCIATION
800 E LEIGH ST SUITE 14RICHMONDVA23219541644709501(C)(6)$18,000SPONSORSHIP
FieldValueIRS element (for citing)
Total501c3 Org42Total501c3OrgCnt
Total Other Org32TotalOtherOrgCnt

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferencePART I, LINE 2:FormAndLineReferenceDesc
ExplanationBIO RELIES ON THE REQUIRED QUALIFICATIONS OF THE GRANT RECIPIENTS TO PROVIDE ASSURANCE OF PROPER USAGE. IN SOME CASES, BIO PERSONNEL ATTEND EVENTS AND RECEIVE ACKNOWLEDGEMENTS RELATED TO THE FUNDS GRANTED.ExplanationTxt

Schedule J IRS990ScheduleJ

FieldValueIRS element (for citing)
First Class Or Charter TravelYes (X)FirstClassOrCharterTravelInd
Travel For CompanionsYes (X)TravelForCompanionsInd
Club Dues Or FeesYes (X)ClubDuesOrFeesInd
Written Policy Ref T And E Expnss0WrittenPolicyRefTAndEExpnssInd
Substantiation RequiredYes (1)SubstantiationRequiredInd
Compensation CommitteeYes (X)CompensationCommitteeInd
Independent ConsultantYes (X)IndependentConsultantInd
Form990 Of Other OrganizationsYes (X)Form990OfOtherOrganizationsInd
Compensation SurveyYes (X)CompensationSurveyInd
Board Or Committee ApprovalYes (X)BoardOrCommitteeApprovalInd
Severance PaymentYes (1)SeverancePaymentInd
Supplemental Nonqual Rtr PlanYes (1)SupplementalNonqualRtrPlanInd
Equity Based Comp Arrngm0EquityBasedCompArrngmInd

Rltd Org Officer Trst Key Empl RltdOrgOfficerTrstKeyEmplGrp (9 entries)

TitleTitleTxtBase Compensation Filing OrgBaseCompensationFilingOrgAmtCompensation Based On Rltd OrgsCompensationBasedOnRltdOrgsAmtBonus Filing OrganizationBonusFilingOrganizationAmountBonus Related OrganizationsBonusRelatedOrganizationsAmtOther Compensation Filing OrgOtherCompensationFilingOrgAmtOther Compensation Rltd OrgsOtherCompensationRltdOrgsAmtDeferred Compensation Flng OrgDeferredCompensationFlngOrgAmtDeferred Comp Rltd OrgsDeferredCompRltdOrgsAmtNontaxable Benefits Filing OrgNontaxableBenefitsFilingOrgAmtNontaxable Benefits Rltd OrgsNontaxableBenefitsRltdOrgsAmtTotal Compensation Filing OrgTotalCompensationFilingOrgAmtTotal Compensation Rltd OrgsTotalCompensationRltdOrgsAmtComp Report Prior990 Filing OrgCompReportPrior990FilingOrgAmtComp Report Prior990 Rltd OrgsCompReportPrior990RltdOrgsAmt
JAMES GREENWOOD
PRESIDENT & CHIEF EXECUTIVE OFFICER$1,623,823$0$910,815$0$0$0$37,000$0$117,112$0$2,688,750$0$0$0
BRENT ERICKSON
EVP, INDUSTRIAL & ENVIRONMENT$522,375$0$119,400$0$326,326$0$6,070$0$10,406$0$984,577$0$0$0
THOMAS DILENGE
PRESIDENT, ADVOCACY/LAW/PUBLIC POLIC$550,000$0$240,497$0$0$0$37,000$0$32,000$0$859,497$0$0$0
JOANNE DUNCAN
PRESIDENT, MEMBERSHIP & BU$530,000$0$240,497$0$0$0$37,000$0$30,121$0$837,618$0$0$0
DANIEL DURHAM
EVP, HEALTH POLICY$464,410$0$126,247$0$0$0$37,000$0$35,535$0$663,192$0$0$0
JEANNE HAGGERTY
EVP, GOVERMENT AFFAIRS & EXTERNAL RE$401,700$0$117,000$0$0$0$35,537$0$13,813$0$568,050$0$0$0
JOSEPH DAMOND
SVP, INTERNATIONAL AFFAIRS$385,074$0$112,157$0$0$0$37,000$0$38,335$0$572,566$0$0$0
ELIZABETH ESHAM
EVP, ECS & VP, SCIENCE & REGULATORY$371,000$0$119,000$0$0$0$37,000$0$15,939$0$542,939$0$0$0
YVETTE WHITE-WIGGINS
SVP & CHIEF FINANCIAL OFFICER$296,717$0$104,000$0$18,584$0$37,785$0$37,144$0$494,230$0$0$0

Supplemental Information Detail SupplementalInformationDetail (3 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
PART I, LINE 1AINCLUDED IN TAXABLE COMPENSATION TO THE INDIVIDUAL -FIRST CLASS OR CHARTER TRAVEL - $2,580 -TRAVEL FOR COMPANIONS - $1,004
PART I, LINE 1BTHE CHIEF EXECUTIVE OFFICER HAS A PREPAID SPENDING ACCOUNT AT A LOCAL RESTAURANT, USED EXCLUSIVELY FOR BUSINESS PURPOSES.
PART I, LINES 4A-BBRENT ERICKSON - SEVERANCE PAYMENT - $398,000 BRENT ERICKSON - 457B PAYOUT - $326,326 MATT LOWE - 457B PAYOUT - $3,885 JAMES GREENWOOD - 457(F) CONTRIBUTION - $727,517

Schedule L IRS990ScheduleL

Bus Tr Involve Interested Prsn BusTrInvolveInterestedPrsnGrp (2 entries)

Relationship DescriptionRelationshipDescriptionTxtTransactionTransactionAmtTransactionTransactionDescSharing Of RevenuesSharingOfRevenuesInd
LAURA GREENWOOD
DAUGHTER OF CEO$79,127PAID EMPLOYEE OF ORGANIZATION0
LILY DOEFLER
DAUGHTER OF A BOARD MEMBER$59,777PAID EMPLOYEE OF ORGANIZATION0

Schedule O IRS990ScheduleO

Supplemental Information Detail SupplementalInformationDetail (9 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
FORM 990, PART VI, SECTION A, LINE 1THE BOARD OF DIRECTORS SHALL DESIGNATE BY RESOLUTION AND WITH A QUORUM PRESENT, NOT MORE THAN NINETEEN (19) DIRECTORS OF THE BOARD TO ACT AS AN EXECUTIVE COMMITTEE. THE EXECUTIVE COMMITTEE SHALL CONSIST OF THE SEVEN (7) ELECTED OFFICERS OF THE ORGANIZATION; THE IMMEDIATE PAST CHAIR OF THE ORGANIZATION; THE VICE CHAIRS OF EACH SECTION'S GOVERNING BOARD; AND THE BALANCE BEING AT-LARGE DIRECTORS FROM THE FULL BOARD. IF THE IMMEDIATE PAST CHAIR IS NO LONGER ELIGIBLE TO SERVE ON THE FULL BOARD, AN ADDITIONAL AT-LARGE DIRECTOR FROM THE FULL BOARD SHALL BE SELECTED FOR THE EXECUTIVE COMMITTEE. THE EXECUTIVE COMMITTEE SHALL HAVE, AND BE AUTHORIZED TO EXERCISE, ALL POWERS OF THE FULL BOARD, EXCEPT: (A) THE POWER TO ELECT OR REMOVE ELECTED OFFICERS OR DIRECTORS, TO CHANGE THE SIZE OF THE BOARD, TO CHANGE ELIGIBILITY, QUALIFICATIONS OR RIGHTS OF MEMBERSHIP, OR TO MAKE DETERMINATIONS AS TO DIRECTOR AND OFFICER COMPENSATION, WHERE APPLICABLE; AND (B) THE POWER TO AMEND THE ARTICLES OF INCORPORATION OR THE BYLAWS OF THE ORGANIZATION.
FORM 990, PART VI, SECTION A, LINE 6THE MEMBERS OF THE ORGANIZATION SHALL BE DIVIDED INTO FOUR CLASSES; CORE MEMBERS, ASSOCIATE MEMBERS, AFFILIATE MEMBERS, AND CENTER MEMBERS, DEFINED AS FOLLOWS: (A) CORE MEMBERS: ANY CORPORATION, PARTNERSHIP, ASSOCIATION, OR OTHER ENTITY ORGANIZED FOR PROFIT, A SUBSTANTIAL PERCENTAGE OF WHOSE BUSINESS ACTIVITIES INVOLVE BIOTECHNOLOGY, GENOMICS, BIOINFORMATICS OR RELATED NEW TECHNOLOGIES, IS ELIGIBLE FOR MEMBERSHIP. CORE MEMBERS ARE THOSE ENTITIES THAT UTILIZE BIOTECHNOLOGY, GENOMICS, BIOINFORMATICS OR OTHER RELATED NEW TECHNOLOGIES IN RESEARCH, DEVELOPMENT, TESTING, MANUFACTURING, OR SALES OF PRODUCT OR INFORMATION, AS WELL AS OTHER FIRMS THE BOARD SO CHARACTERIZES AND PLACES IN THIS CATEGORY. CORE MEMBERS SHALL BE GROUPED IN THE FOLLOWING SUBCATEGORIES: (I) EMERGING COMPANIES, WHICH ARE FIRMS THAT EMPLOY LESS THAN 350 PERSONS AND THAT DO NOT HAVE A THERAPEUTIC OR DIAGNOSTIC PRODUCT APPROVED FOR SALE IN THE U.S. MARKET; (II) ESTABLISHED FIRMS, WHICH ARE THOSE FIRMS THAT EMPLOY 350 OR MORE PERSONS OR THAT HAVE A THERAPEUTIC OR DIAGNOSTIC PRODUCT APPROVED FOR SALE IN THE U.S. MARKET; AND (III) LARGE FIRMS, WHICH ARE ESTABLISHED FIRMS THAT HAVE ANNUAL WORLDWIDE SALES OF BIOTECHNOLOGY PRODUCTS IN EXCESS OF $1.5 BILLION; AND (IV) NON-DOMESTIC COMPANIES, WHICH ARE CORE MEMBERS WITHOUT SIGNIFICANT OPERATIONS IN THE UNITED STATES OR SIGNIFICANT COLLABORATIONS WITH A U.S. ENTITY. (B) ASSOCIATE MEMBERS: ANY CORPORATION, PARTNERSHIP, ASSOCIATION, OR OTHER ENTITY ORGANIZED FOR PROFIT, A SUBSTANTIAL PORTION OF WHOSE ACTIVITIES INVOLVE PROVIDING SERVICES OR PRODUCTS OF BENEFIT TO COMPANIES WHOSE PRINCIPAL BUSINESS IS BIOTECHNOLOGY, IS ELIGIBLE FOR ASSOCIATE MEMBERSHIP. ASSOCIATE MEMBERS ARE THOSE COMMERCIAL ENTITIES WHICH DO NOT NECESSARILY UTILIZE BIOTECHNOLOGY; E.G. TECHNICAL SUPPORT, EQUIPMENT, CONSTRUCTION, ACCOUNTING, AND LAW FIRMS THAT SERVICE THE BIOTECHNOLOGY INDUSTRY, AS WELL AS OTHER FIRMS THAT THE BOARD CHARACTERIZES AND PLACES IN THIS CATEGORY. (C) AFFILIATE MEMBERS: ANY GOVERNMENTAL OR NONPROFIT ENTITY OR COUNTRY, STATE OR REGIONAL INDUSTRY, TRADE OR PROFESSIONAL ASSOCIATION WITH AN INTEREST IN, OR A MANDATE TO PROMOTE THE DEVELOPMENT OF, BIOTECHNOLOGY IS ELIGIBLE FOR AFFILIATE MEMBERSHIP. THERE SHALL BE NO SIZE TESTS APPLIED TO AFFILIATE MEMBER APPLICANTS. (D) CENTER MEMBERS: ANY INSTITUTION, NOT GENERALLY ELIGIBLE FOR CORE MEMBERSHIP THAT IS SPONSORED BY A STATE, REGION, OR ACADEMIC INSTITUTION AND WORKS IN SUPPORT OF COMMERCIAL BIOTECHNOLOGY MAY BE ELIGIBLE FOR CONSIDERATION AS A CENTER MEMBER.
FORM 990, PART VI, SECTION A, LINE 7AAT ALL MEMBERSHIP MEETINGS OF THE ORGANIZATION, EACH CURRENT MEMBER SHALL HAVE ONE (1) VOTE AND MAY TAKE PART IN THE VOTING IN PERSON OR BY PROXY. FOR EACH SECTION IN WHICH THE MEMBER PARTICIPATES, EACH MEMBER SHALL HAVE THE RIGHT TO VOTE ON THE ELECTION OF DIRECTORS FOR THE SECTION GOVERNING BOARD, BUT SHALL HAVE NO OTHER VOTING RIGHTS EXCEPT ON MATTERS BROUGHT TO THE MEMBERSHIP BY ANY SUCH GOVERNING BOARD OR THE ORGANIZATION'S BOARD OF DIRECTORS.
FORM 990, PART VI, SECTION B, LINE 11BTHE FORM 990 AND RELATED SCHEDULES ARE PREPARED BY THE ORGANIZATION'S CERTIFIED PUBLIC ACCOUNTANTS UNDER THE GUIDANCE OF THE CHIEF FINANCIAL OFFICER (CFO). THE CFO AND THE CONTROLLER THOROUGHLY REVIEW ALL CALCULATIONS AND SCHEDULES TO CONFIRM THEY REFLECT THE ACTUAL FINANCIAL RESULTS OF THE ORGANIZATION. THE COMPLETE FORM 990 IS THEN REVIEWED INTERNALLY BY THE CEO, DIVISION PRESIDENTS, CFO, AND CONTROLLER IN CONSULTATION WITH LEGAL COUNSEL AND, AS APPROPRIATE, FURTHER CONSULTATION WITH THE ORGANIZATION'S CERTIFIED PUBLIC ACCOUNTANTS. FINALLY, THE FORM 990 IS PROVIDED TO THE CHAIRMAN OF THE BOARD AND BIO EXECUTIVE COMMITTEE MEMBERS FOR THEIR REVIEW, QUESTIONS AND/OR COMMENTS. ALL REVIEWS ARE COMPLETED BEFORE THE FORM IS FILED WITH THE IRS.
FORM 990, PART VI, SECTION B, LINE 12CBIOTECHNOLOGY INNOVATION ORGANIZATION (BIO) TAKES SEVERAL STEPS TO ADDRESS COMPLIANCE BY EMPLOYEES AND DIRECTORS WITH ITS CONFLICTS OF INTEREST POLICY. BIO TRAINS ALL NEW EMPLOYEES AND DIRECTORS ON VARIOUS ASPECTS OF BIO'S COMPLIANCE PROGRAM, INCLUDING CONFLICTS OF INTEREST, AND BIO'S WRITTEN CONFLICTS OF INTEREST POLICY REQUIRES ALL EMPLOYEES TO DISCLOSE ANY OUTSIDE PERSONAL BUSINESS INTERESTS TO THEIR SUPERVISOR. BIO'S GENERAL COUNSEL REGULARLY ADVISES BIO'S EXECUTIVES AND SUPERVISORS ON SUCH MATTERS. BIO ALSO CONTRACTS WITH AN INDEPENDENT ORGANIZATION TO PROVIDE EMPLOYEES AND OTHERS WITH THE ABILITY TO FILE ANONYMOUS REPORTS CONCERNING THE VIOLATION OF ANY LAWS OR BIO POLICIES, INCLUDING ALLEGATIONS OF POTENTIAL CONFLICTS OF INTEREST, AND BIO HAS A PROCESS IN PLACE TO FOLLOW UP ON ANY SUCH COMPLAINTS IN A TIMELY AND THOROUGH MANNER. FURTHER, BIO UNDERTAKES A QUESTIONNAIRE SENT TO EACH DIRECTOR ON ITS BOARD OF DIRECTORS SEEKING DISCLOSURE OF ANY POTENTIAL CONFLICTS OF INTERESTS THEY MAY HAVE, OR THEIR FAMILY MEMBERS MAY HAVE, ASSOCIATED WITH BUSINESSES OR ORGANIZATIONS THAT DO BUSINESS WITH BIO. POTENTIAL CONFLICTS ARE MONITORED AND REVIEWED AT THE MANAGEMENT AND SENIOR MANAGEMENT LEVEL OF THE ORGANIZATION, AND DEPENDING ON THE CONFLICT, DETERMINATIONS MAY BE MADE AT THE BOARD OR SENIOR MANAGEMENT LEVEL. A CONFLICT AT THE BOARD LEVEL WILL NORMALLY RESULT IN RECUSAL OF THE INDIVIDUAL FROM PARTICIPATION OR ACTIVITIES WITH RESPECT TO THE RELEVANT SUBJECT MATTER. AT THE STAFF LEVEL, THE APPLICABLE BIO SUPERVISOR IS INFORMED OF THE POTENTIAL CONFLICT AND IS REQUIRED TO TAKE ALL APPROPRIATE STEPS TO ENSURE THAT THE INDIVIDUAL DOES NOT PARTICIPATE IN, OR RECEIVE CONFIDENTIAL INFORMATION RELATING TO, ANY BIO ACTIVITY RELATED TO THE SUBJECT MATTER OF THE CONFLICT, UP TO AND INCLUDING, WHERE APPROPRIATE, TERMINATION OF SUCH EMPLOYEE.
FORM 990, PART VI, SECTION B, LINE 15FOR 2019, THE PRESIDENT AND CHIEF EXECUTIVE OFFICER (CEO) OF BIO WAS COMPENSATED PER THE TERMS OF A MULTI-YEAR CONTRACT THAT WAS DETERMINED WITH INDEPENDENT REVIEW, COMPARABILITY DATA, AND CONTEMPORANEOUS SUBSTANTIATION OF THE DELIBERATION AND DECISION AS INDICATED IN PRIOR FORM 990 SUBMISSIONS. IN ADDITION, BASED ON THE EXECUTIVE COMMITTEE'S EVALUATION OF THE PRESIDENT AND CEO'S PERFORMANCE FOR 2019, THE COMMITTEE DETERMINED THE APPROPRIATE AMOUNT FOR THE DISCRETIONARY COMPONENT OF HIS COMPENSATION FOR THAT YEAR, IN ACCORDANCE WITH THE RELEVANT PROVISION OF THE EXECUTIVE AGREEMENT. DECISIONS REGARDING THE COMPENSATION FOR OFFICERS AND KEY EMPLOYEES OF THE ORGANIZATION ARE NEGOTIATED INDIVIDUALLY AND ARE PERFORMANCE-BASED, IN ACCORDANCE WITH AN ANNUAL WRITTEN EVALUATION PROCESS THAT HAS BEEN ESTABLISHED FOR ALL EMPLOYEES OF THE ORGANIZATION. THE PRESIDENTS OF THE TWO DIVISIONS AT BIO LED THE PROCESS, IN COORDINATION WITH THE PRESIDENT & CEO. AN INDEPENDENT CONSULTANT PROVIDES COMPARATIVE BENCHMARKING SERVICES FOR SENIOR MANAGEMENT POSITIONS, AND OTHER INFORMATION ON COMPENSATION ISSUES, TRENDS, POLICIES, AND BEST PRACTICES FOR USE BY THE ORGANIZATION. THE ORGANIZATION ALSO HAS AN ESTABLISHED COMPENSATION POLICY FOR ALL OF ITS EMPLOYEES, WHICH SETS FORTH THE GENERAL PARAMETERS GOVERNING BIO'S COMPENSATION PRACTICES.
FORM 990, PART VI, SECTION C, LINE 19THE ORGANIZATION DOES NOT MAKE ITS GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FINANCIAL STATEMENTS AVAILABLE TO THE PUBLIC.
FORM 990, PART IX, LINE 11GEC EMERGING PRIORITIES 13,212,145. WORKPLAN OBJECTIVES 149,698. I&E INITIATIVES 1,027. INTERNS 46,485. TEMPORARY HELP 175,501. CEO DELEGATION EXPENSE 22,804. ECONOMIC STUDIES 764,241. CONSULTANTS AND OTHER PROFESSIONAL FEES 401,459. BIO-PAC ADMINISTRATIVE 34,513. BUSINESS DEVELOPMENT EXEC PRESENTATION 60,018. PROGRAM INITIATIVES 39,280. RECRUITMENT 208,835. BUSINESS STRATEGIES 33,391. EDUCATION 91,293.
FORM 990, PART XI, LINE 9:DEFERRED SPONSORSHIP EXPENSE 98,200. NET EXCLUSIVE BUSINESS SOLUTION 30,000.

Schedule R IRS990ScheduleR

Id Related Tax Exempt Org IdRelatedTaxExemptOrgGrp (2 entries)

Address Line1USAddress/AddressLine1TxtCityUSAddress/CityNmState AbbreviationUSAddress/StateAbbreviationCdZIPUSAddress/ZIPCdEINEINPrimary ActivitiesPrimaryActivitiesTxtLegal Domicile StateLegalDomicileStateCdExempt Code SectionExemptCodeSectionTxtControlled OrganizationControlledOrganizationIndPublic Charity StatusPublicCharityStatusTxt
EXCELLENCE THROUGH STEWARDSHIP
1201 MARYLAND AVE SW SUITE 900WASHINGTONDC20024263021330TO SUPPORT THE PURSUIT OF LIFELONG LEARNING ABOUT THE PROMISE, ACHIEVEMENTSDC501(C)(4)0
BIOTECHNOLOGY INSTITUTE
1201 MARYLAND AVE SW SUITE 900WASHINGTONDC20024251716917TO SUPPORT THE PURSUIT OF LIFELONG LEARNING ABOUT THE CHALLENGES OF BIOTECH.DC501(C)(3)0LINE 7
FieldValueIRS element (for citing)
Receipt Of Int Annts Rnts Rylts0ReceiptOfIntAnntsRntsRyltsInd
Gift Grnt Or Cap Contri To Oth OrgYes (1)GiftGrntOrCapContriToOthOrgInd
Gift Grnt Cap Contri From Oth Org0GiftGrntCapContriFromOthOrgInd
Loans Or Guarantees To Other OrgYes (1)LoansOrGuaranteesToOtherOrgInd
Loans Or Guarantees From Oth Org0LoansOrGuaranteesFromOthOrgInd
Div Related Organization0DivRelatedOrganizationInd
Asset Sale To Other Org0AssetSaleToOtherOrgInd
Asset Purchase From Other Org0AssetPurchaseFromOtherOrgInd
Asset Exchange0AssetExchangeInd
Rental Of Facilities To Oth Org0RentalOfFacilitiesToOthOrgInd
Rental Of Fclts From Oth Org0RentalOfFcltsFromOthOrgInd
Perform Of Services For Oth Org0PerformOfServicesForOthOrgInd
Perform Of Services By Other Org0PerformOfServicesByOtherOrgInd
Sharing Of Facilities0SharingOfFacilitiesInd
Paid Employees Sharing0PaidEmployeesSharingInd
Reimbursement Paid To Other Org0ReimbursementPaidToOtherOrgInd
Reimbursement Paid By Other OrgYes (1)ReimbursementPaidByOtherOrgInd
Transfer To Other Org0TransferToOtherOrgInd
Transfer From Other Org0TransferFromOtherOrgInd